Sujit Basu, MD, PhD
College of Medicine
>Cancer ● Wounds and Injuries ● Carcinoma ● Stomach Cancer ● Leukemia, Lymphocytic, Chronic, B-Cell ● Neutropenia ● Papilloma ● Ascites
Sujit Basu, MD, PhD, is a member of the Translational Therapeutics Program at the OSUCCC – James. His research explores the role of endogenous factors regulating tumor microenvironment, including tumor neovascularization and the development of new therapies.
One of his recent studies indicates that dopamine may be used safely as an antiangiogenic drug to treat malignant tumors.
Dr. Basu has co-authored numerous articles in well-respected publications, such as Nature Medicine, Journal of Clinical Investigation, PNAS and Cancer Research.